Table 4 Symptoms of toxicity or withdrawal experienced after SCs use
From: Clinical pattern of synthetic cannabinoids users in Upper Egypt: cross-sectional study
| Â | Number N = 50 | Percentage (%) |
|---|---|---|
Neuro-psychiatric effects | ||
 Dizziness/Drowsiness | 34 | 68% |
 Headache | 11 | 22% |
 Seizures | 4 | 8% |
 Irritability/agitation | 2 | 4% |
 Auditory and visual hallucination | 29 | 58% |
 Auditory only hallucination | 2 | 4% |
 Panic attack (fear of death) | 13 | 26% |
 Psychosis | 1 | 2% |
Cardiovascular effects | ||
 Palpitation | 38 | 76% |
 Chest Pain | 6 | 12% |
Gastrointestinal effect | ||
 Nausea and vomiting | 12 | 24% |
Others | ||
 Blurred vision and red eye | 44 | 88% |
 Withdrawal manifestation | 10 | 20% |
 No symptoms were experienced | 2 | 4% |